Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
Why One Analyst Thinks Johnson & Johnson Reaches $280
11:56am, Tuesday, 17'th Mar 2026
Johnson & Johnson ( NYSE:JNJ ) has been one of healthcare's standout performers over the past year, with shares up 48% over the past 12 months and 16% year-to-date.
JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study
02:00pm, Monday, 16'th Mar 2026
J&J reports phase I study win for Erda-iDRS in NMIBC, showing strong response rates, durable control and manageable safety as mid-to-late-stage studies advance.
Your Tax Refund Will Probably Be Bigger This Year. Here's What to Do With It.
12:30pm, Monday, 16'th Mar 2026
There are still reliable stocks to consider for investing your tax refund this year.
Johnson & Johnson Drives Innovation in Pulsed Field Ablation with Peru Launch
11:00am, Monday, 16'th Mar 2026
LIMA, Peru--(BUSINESS WIRE)--Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This i
Johnson & Johnson $JNJ Shares Bought by Brown Brothers Harriman & Co.
06:52am, Saturday, 14'th Mar 2026
Brown Brothers Harriman and Co. raised its holdings in Johnson and Johnson (NYSE: JNJ) by 2.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commis
Bank of Hawaii Reduces Stock Holdings in Johnson & Johnson $JNJ
03:07am, Saturday, 14'th Mar 2026
Bank of Hawaii decreased its position in Johnson and Johnson (NYSE: JNJ) by 5.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi
Plaintiffs alleged the anticompetitive scheme forced Tracleer purchasers to pay higher prices and delayed market entry of less-costly generic versions.
Johnson & Johnson (JNJ) Could Be a Great Choice
12:45pm, Friday, 13'th Mar 2026
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Data presented at EAU 2026 show an 89 percent complete response rate in intermediate-risk disease with durable responses observed over 18 months and tolerable safety profile Erda-iDRS has the potent
The 5 Safest Dividend Kings Are the Only Stocks to Buy Now
07:42am, Friday, 13'th Mar 2026
The stock market could face serious trouble as 2026 heads into the second quarter under duress.
American Investment Services Inc. Purchases 2,152 Shares of Johnson & Johnson $JNJ
04:50am, Friday, 13'th Mar 2026
American Investment Services Inc. raised its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 10.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchan
Johnson & Johnson (NYSE:JNJ) Receives Consensus Recommendation of “Moderate Buy” from Analysts
04:12am, Friday, 13'th Mar 2026
Shares of Johnson and Johnson (NYSE: JNJ - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the twenty-seven research firms that are presently covering the firm, MarketBe
Growing Your Income vs. Maximizing It Now: The Core Difference Between VIG and HDV
03:23pm, Thursday, 12'th Mar 2026
Explore how sector focus and portfolio diversity set these two leading dividend ETFs apart for income and growth-minded investors.
The Best Dividend Stocks to Buy and Hold Forever
01:30pm, Thursday, 12'th Mar 2026
Johnson & Johnson and AbbVie have successful, diversified healthcare businesses. History suggests they will maintain their dividend programs for many more years.
Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients
08:00am, Thursday, 12'th Mar 2026
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients.
